CEL-SCI Market Cap

CEL-SCI has a market cap or net worth of $23.04 million as of November 2, 2026. It is the 35,381st most valuable company in the world and the 5,093rd biggest in the United States. Its market cap has decreased by 52.78% in one year.

Market Cap

23.04M

Enterprise Value

24.41M

1-Year Change

-52.78%

Global Rank

#35,381

Country Rank

#5,093 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, CEL-SCI's market cap has decreased from $27.40M to $23.04M, a decrease of -15.91%. That is a compound annual growth rate of -0.62%.

Market Cap History

Date	Market Cap	% Change
Nov 2, 2026	23.04M	-47.87%
Dec 31, 2025	44.20M	79.67%
Dec 31, 2024	24.60M	-81.90%
Dec 29, 2023	135.90M	32.46%
Dec 30, 2022	102.60M	-66.58%
Dec 31, 2021	307.00M	-33.78%
Dec 31, 2020	463.60M	43.22%
Dec 31, 2019	323.70M	297.18%
Dec 31, 2018	81.50M	226.00%
Dec 29, 2017	25.00M	96.85%
Dec 30, 2016	12.70M	-73.60%
Dec 31, 2015	48.10M	-9.42%
Dec 31, 2014	53.10M	80.61%
Dec 31, 2013	29.40M	-60.16%
Dec 31, 2012	73.80M	10.81%
Dec 30, 2011	66.60M	-60.45%
Dec 31, 2010	168.40M	25.11%
Dec 31, 2009	134.60M	300.60%
Dec 31, 2008	33.60M	-42.37%
Dec 31, 2007	58.30M	27.85%
Dec 29, 2006	45.60M	25.27%
Dec 30, 2005	36.40M	-15.74%
Dec 31, 2004	43.20M	-37.39%
Dec 31, 2003	69.00M	845.21%
Dec 31, 2002	7.30M	-67.12%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
TransCode Therapeutics	27.60M
BriaCell Therapeutics	26.81M
BeyondSpring	26.47M
Polyrizon	26.11M
ABVC BioPharma	25.96M
Celularity	25.96M
Evaxion	24.44M
CervoMed	24.19M

Market Cap Rankings